Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Influenza Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Drugsmarket, defines the market attractiveness level of Influenza Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Influenza Drugs industry, describes the types of Influenza Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Drugs market and the development prospects and opportunities of Influenza Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Drugs market in Chapter 13.
By Player:
Emergent Biosolutions
Protein Sciences Corporation
Roche
Bayer
Bristol-Myers Squibb]
Alvogen
Sanofi Pasteur
AstraZeneca
Seqirus
BioCryst Pharmaceuticals
Pfizer
Novartis
GlaxoSmithKline
Serum Institute of India
Celgene
Eli Lilly
By Type:
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
By End-User:
Adults
Chidren
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Influenza Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Influenza Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Influenza Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Influenza Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Influenza Drugs Market Analysis and Outlook to 2022
-
7.1 Global Influenza Drugs Consumption (2017-2022)
-
7.2 United States Influenza Drugs Consumption (2017-2022)
-
7.3 Europe Influenza Drugs Consumption (2017-2022)
-
7.4 China Influenza Drugs Consumption (2017-2022)
-
7.5 Japan Influenza Drugs Consumption (2017-2022)
-
7.6 India Influenza Drugs Consumption (2017-2022)
-
7.7 South Korea Influenza Drugs Consumption (2017-2022)
8 Region and Country-wise Influenza Drugs Market Analysis and Outlook to 2028
-
8.1 Global Influenza Drugs Consumption Forecast (2022-2028)
-
8.2 United States Influenza Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Influenza Drugs Consumption Forecast (2022-2028)
-
8.4 China Influenza Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Influenza Drugs Consumption Forecast (2022-2028)
-
8.6 India Influenza Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Influenza Drugs Consumption Forecast (2022-2028)
9 Global Influenza Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Influenza Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Zanamivir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peramivir Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Influenza Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Influenza Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chidren Consumption and Growth Rate (2017-2022)
10 Global Influenza Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Influenza Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Peramivir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Influenza Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chidren Consumption Forecast and Growth Rate (2022-2028)
11 Global Influenza Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Influenza Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Influenza Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Influenza Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Influenza Drugs Market Competitive Analysis
-
14.1 Emergent Biosolutions
-
14.1.1 Emergent Biosolutions Company Details
-
14.1.2 Emergent Biosolutions Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Emergent Biosolutions Influenza Drugs Product and Service
-
14.2 Protein Sciences Corporation
-
14.2.1 Protein Sciences Corporation Company Details
-
14.2.2 Protein Sciences Corporation Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Protein Sciences Corporation Influenza Drugs Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Influenza Drugs Product and Service
-
14.4 Bayer
-
14.4.1 Bayer Company Details
-
14.4.2 Bayer Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Influenza Drugs Product and Service
-
14.5 Bristol-Myers Squibb]
-
14.5.1 Bristol-Myers Squibb] Company Details
-
14.5.2 Bristol-Myers Squibb] Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb] Influenza Drugs Product and Service
-
14.6 Alvogen
-
14.6.1 Alvogen Company Details
-
14.6.2 Alvogen Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Alvogen Influenza Drugs Product and Service
-
14.7 Sanofi Pasteur
-
14.7.1 Sanofi Pasteur Company Details
-
14.7.2 Sanofi Pasteur Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Pasteur Influenza Drugs Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Influenza Drugs Product and Service
-
14.9 Seqirus
-
14.9.1 Seqirus Company Details
-
14.9.2 Seqirus Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Seqirus Influenza Drugs Product and Service
-
14.10 BioCryst Pharmaceuticals
-
14.10.1 BioCryst Pharmaceuticals Company Details
-
14.10.2 BioCryst Pharmaceuticals Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BioCryst Pharmaceuticals Influenza Drugs Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Influenza Drugs Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Influenza Drugs Product and Service
-
14.13 GlaxoSmithKline
-
14.13.1 GlaxoSmithKline Company Details
-
14.13.2 GlaxoSmithKline Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 GlaxoSmithKline Influenza Drugs Product and Service
-
14.14 Serum Institute of India
-
14.14.1 Serum Institute of India Company Details
-
14.14.2 Serum Institute of India Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Serum Institute of India Influenza Drugs Product and Service
-
14.15 Celgene
-
14.15.1 Celgene Company Details
-
14.15.2 Celgene Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Celgene Influenza Drugs Product and Service
-
14.16 Eli Lilly
-
14.16.1 Eli Lilly Company Details
-
14.16.2 Eli Lilly Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Eli Lilly Influenza Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Influenza Drugs
-
Figure Influenza Drugs Picture
-
Table Global Influenza Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Influenza Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Influenza Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Influenza Drugs Consumption by Country (2017-2022)
-
Figure United States Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Zanamivir Consumption and Growth Rate (2017-2022)
-
Figure Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)
-
Figure Global Peramivir Consumption and Growth Rate (2017-2022)
-
Figure Global Other Influenza Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Chidren Consumption and Growth Rate (2017-2022)
-
Figure Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peramivir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Influenza Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chidren Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Influenza Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Influenza Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Emergent Biosolutions (Foundation Year, Company Profile and etc.)
-
Table Emergent Biosolutions Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent Biosolutions Influenza Drugs Product and Service
-
Table Protein Sciences Corporation (Foundation Year, Company Profile and etc.)
-
Table Protein Sciences Corporation Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protein Sciences Corporation Influenza Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Influenza Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Influenza Drugs Product and Service
-
Table Bristol-Myers Squibb] (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb] Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb] Influenza Drugs Product and Service
-
Table Alvogen (Foundation Year, Company Profile and etc.)
-
Table Alvogen Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alvogen Influenza Drugs Product and Service
-
Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)
-
Table Sanofi Pasteur Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur Influenza Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Influenza Drugs Product and Service
-
Table Seqirus (Foundation Year, Company Profile and etc.)
-
Table Seqirus Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seqirus Influenza Drugs Product and Service
-
Table BioCryst Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table BioCryst Pharmaceuticals Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCryst Pharmaceuticals Influenza Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Influenza Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Influenza Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Influenza Drugs Product and Service
-
Table Serum Institute of India (Foundation Year, Company Profile and etc.)
-
Table Serum Institute of India Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Influenza Drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Influenza Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Influenza Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Influenza Drugs Product and Service
-
